PD1-PDL1 inhibitor 1

CAS No. 1675201-83-8

PD1-PDL1 inhibitor 1( PD-1/PD-L1 inhibitor 1 )

Catalog No. M12558 CAS No. 1675201-83-8

PD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 76 In Stock
5MG 73 In Stock
10MG 109 In Stock
25MG 208 In Stock
50MG 305 In Stock
100MG 461 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD1-PDL1 inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    PD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.
  • Description
    PD1-PDL1 inhibitor 1 (CAS 1675201-83-8) is a potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.
  • In Vitro
    Cell Cytotoxicity Assay Cell Line:NK cells and HepG2 cells Concentration:1 μM Incubation Time:3 days Result:Disturbed the interaction between PD-1 and PD-L1.
  • In Vivo
    Animal Model:BALB/c mice with EMT6 cells Dosage:500 μg/mL; 100 μL Administration:I.p.Result:Increased the survival rates of the mVEGF165b group and mVEGF165b + MUC1 group.mVEGF165b combined with MUC1 results significant retardation of the tumor growth.
  • Synonyms
    PD-1/PD-L1 inhibitor 1
  • Pathway
    Immunology/Inflammation
  • Target
    PD-1/PD-L1
  • Recptor
    PD-1/PD-L1
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1675201-83-8
  • Formula Weight
    475.576
  • Molecular Formula
    C29H33NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 29 mg/mL
  • SMILES
    O=C([C@H]1N(CC2=C(OC)C=C(OCC3=CC=CC(C4=CC=CC=C4)=C3C)C=C2OC)CCCC1)O
  • Chemical Name
    2-Piperidinecarboxylic acid, 1-[[2,6-dimethoxy-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-, (2S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chupak, L.S., and Zheng, X. Compounds useful as immunomodulators. PCT/US2014/053695, (2015).
molnova catalog
related products
  • Nofazinlimab

    Nofazinlimab (CS1003) is a human anti-PD-1 IgG4 monoclonal antibody used to study unresectable hepatocellular carcinoma (uHCC) and metastatic colorectal cancer.

  • IMMH 010 maleate

    IMMH 010 maleate (YPD-30 maleate) is an orally available programmed cell death ligand 1 inhibitor with potential antitumor activity for the study of neurological disorders and advanced malignant solid tumors.

  • Camrelizumab

    Camrelizumab (SHR-1210) is a human IgG4-κ monoclonal antibody with high affinity directed against PD-1, binding PD-1 with an affinity of up to 3 nM and inhibiting PD-1/PD-L1 with an IC50 of 0.70 nM.